SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-165684
Filing Date
2024-06-21
Accepted
2024-06-21 16:15:54
Documents
13
Period of Report
2024-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d847854d8k.htm   iXBRL 8-K 22200
  Complete submission text file 0001193125-24-165684.txt   151464

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krro-20240617.xsd EX-101.SCH 2893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krro-20240617_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krro-20240617_pre.xml EX-101.PRE 12185
17 EXTRACTED XBRL INSTANCE DOCUMENT d847854d8k_htm.xml XML 3942
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 241060377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)